Stock JNJB34 JOHNSON & JOHNSON
Add to a list
To use this feature you must be a member
Log inSign up

News Johnson & Johnson Sao Paulo

Equities

JNJB34

BRJNJBBDR002

Delayed Sao Paulo
Other stock markets
 18:39:38 31/05/2024 BST 		5-day change 1st Jan Change
51.45 BRL +0.94% Intraday chart for Johnson & Johnson +0.98% +1.92%
07:30pm Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars MT
03:42pm J&J: completes acquisition of Shockwave Medical CF

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars
MT
Johnson & Johnson Executive Vice President, William N. Hait, M.D., Ph.D., to Retire, Effective September 2024
AQ
J&J: completes acquisition of Shockwave Medical
CF
Johnson & Johnson Closes Acquisition of Shockwave Medical
MT
Johnson & Johnson Completes Acquisition of Shockwave Medical
MT
Johnson & Johnson Completes Acquisition of Shockwave Medical
BU
Johnson & Johnson completed the acquisition of Shockwave Medical, Inc. from a group of sellers.
CI
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400
MT
Johnson & Johnson : to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) Press Release
PU
Transcript : Johnson & Johnson Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-29-2024 01:30 PM
J&J: encouraging results in the treatment of depression
CF
Johnson & Johnson's Phase 3 Trial of Seltorexant to Treat Major Depressive Disorder Meets Primary, Secondary Endpoints
MT
J&J's treatment for depression succeeds in late stage study
RE
Johnson & Johnson Announces Pivotal Study of Seltorexant Shows Statistically Significant and Clinically Meaningful Improvement in Depressive Symptoms and Sleep Disturbance Outcomes
CI
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results
AQ
Sector Update: Health Care Stocks Fall Late Afternoon
MT
Sector Update: Health Care Stocks Retreat Tuesday Afternoon
MT
Sector Update: Health Care
MT
Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK
MT
Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. JNJ Stock
  4. JNJB34 Stock
  5. News Johnson & Johnson